NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-162-1990-0-US-07 SUSTAINED AND CONTINUOUS PRODUCTION OF HIGH TITERS OF RECOMBINANT VIRAL VECTORS AND TRANSDUCED TARGET CELLS... US FWC 08/068,605 Abandoned
NCI E-317-1984-6-US-05 Antibodies Which Bind With Proteins of Human Immunodeficiency Virus Type 1 (HIV-1), and Immune Complexes Comprising Proteins of HIV-1. US DIV 08/067,148 7122188 Expired PDF
NIAMS E-247-1988-3-US-03 POLYPEPTIDE AND DNA SEQUENCE CORRESPONDING TO THE HUMAN RECEPTOR WITH HIGH AFFINITY FOR IgE US CON 08/066,639 Abandoned
NHLBI E-189-1993-0-US-01 FUSION PROTEINS CONTAINING ADENO-ASSOCIATED VIRUS REP PROTEIN AND EXPRESSION VEHICLES CONTAINING DNA ENCODING SUCH PROTEINS US ORD 08/067,236 Abandoned
NCI E-062-1993-0-US-01 METHODS OF INHIBITING VIRAL REPLICATION USING IL-10 US ORD 08/066,785 5665345 Expired PDF
NHLBI E-156-1992-0-CA-03 IMPROVED EXPRESSION OF HUMAN MULTIDRUG RESISTANCE GENES AND IMPROVED SELECTION OF CELLS TRANSDUCED WITH SUCH GENES CA National Stage 2135645 Abandoned
NCI E-059-1992-1-US-01 CALANOLIDE AND RELATED ANTIRETROVIRAL COMPOUNDS, COMPOSITIONS, AND USES THEROF US CIP 08/065,618 5591770 Expired PDF
NCI E-064-1992-0-PCT-02 TARGETING GENE EXPRESSION TO LIVING TISSUE USING JET INJECTION PCT PCT PCT/US1993/004831 Expired
NCI E-157-1993-0-US-01 NEW PROCEDURE TO BLOCK THE REPLICATION OF REVERSE TRANSCRIPTASE DEPEN- DENT VIRUSES BY THE USE OF INHIBITORS OF DEOXYNUCLEOTIDES SYNTHESIS US ORD 08/065,814 Abandoned
NCI E-051-1992-0-JP-21 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT JP National Stage 1994-500941 Abandoned
NCI E-051-1992-0-CA-18 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT CA National Stage 2136094 Abandoned
NCI E-051-1992-0-DK-09 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT DK EP 93914044.8 Abandoned
NCI E-051-1992-0-LU-04 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT LU EP 93914044.8 Abandoned
NCI E-051-1992-0-IT-16 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT IT EP 93914044.8 Abandoned
NCI E-051-1992-0-IE-11 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT IE EP 93914044.8 Abandoned
NCI E-051-1992-0-GR-10 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT GR EP 3025500 Abandoned
NCI E-051-1992-0-FR-15 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT FR EP 93914044.8 Abandoned
NCI E-051-1992-0-DE-19 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT DE EP 93914044.8 Abandoned
NCI E-051-1992-0-BE-07 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT BE EP 93914044.8 Abandoned
NCI E-051-1992-0-AT-06 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT AT EP 93914044.8 Abandoned
NCI E-051-1992-0-NL-12 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT NL EP 93914044.8 Abandoned
NCI E-051-1992-0-ES-03 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT ES EP 93914044.8 Abandoned
NCI E-051-1992-0-MC-05 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT MC EP 93914044.8 Abandoned
NCI E-051-1992-0-PT-13 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT PT EP 93914044.8 Abandoned
NCI E-051-1992-0-GB-22 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT GB EP 93914044.8 Abandoned
NCI E-051-1992-0-CH-08 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT CH EP 93914044.8 Abandoned
NCI E-051-1992-0-SE-14 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT SE EP 93914044.8 Abandoned
NCI E-051-1992-0-EP-20 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT EP National Stage 93914044.8 Expired
NCI E-051-1992-0-AU-17 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT AU National Stage 43857/93 Abandoned
NCI E-066-1991-1-US-01 METHOD OF INHIBITING NEOPLASIA AND TUMOR PROMOTION US CIP 08/064,251 5405875 Expired PDF
NCI E-051-1992-0-PCT-02 METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT PCT PCT PCT/US1993/004826 Abandoned
NCI E-120-1992-1-US-01 IMMORTALIZED HUMAN CELL LINES CONTAINING EXOGENOUS CYTOCHROME P450 GENES US CIP 08/065,201 5506131 Expired PDF
NIAID E-154-1993-0-US-01 IMMUNOLOGIC ENHANCEMENT WITH INTERMITTENT INTERLEUKIN-2 THERAPY US ORD 08/063,315 5419900 Expired PDF
NCI E-216-1987-1-US-02 METHOD FOR DETECTING CARCINOMA US FWC 08/062,717 5604106 Abandoned PDF
NCI E-152-1991-1-US-01 Peptides Which Elicit A High Neutralizing Antibody Titer, Cytotoxic T Lymphocyte Response and T Helper Cell Response In A Broad Range of... US CIP 08/060,988 6294322 Expired PDF
NCI E-149-1993-0-US-01 VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE US ORD 08/061,889 5654138 Expired PDF
NHLBI E-152-1993-0-PCT-02 Vector Particles Resistant to Inactivation by Human Serum PCT PCT PCT/US1993/004706 Expired
NHLBI E-156-1992-0-PCT-02 IMPROVED EXPRESSION OF HUMAN MULTIDRUG RESISTANCE GENES AND IMPROVED SELECTION OF CELLS TRANSDUCED WITH SUCH GENES PCT PCT PCT/US1993/004707 Expired
NHLBI E-152-1993-0-JP-06 VECTOR PARTICLES RESISTANT TO INACTIVATION BY HUMAN SERUM JP National Stage 05-501479 Expired
NHLBI E-156-1992-0-EP-04 IMPROVED EXPRESSION OF HUMAN MULTIDRUG RESISTANCE GENES AND IMPROVED SELECTION OF CELLS TRANSDUCED WITH SUCH GENES EP National Stage 93913965.5 Expired
NHLBI E-152-1993-0-EP-05 VECTOR PARTICLES RESISTANT TO INACTIVATION BY HUMAN SERUM EP National Stage 93913964.8 Abandoned
NHLBI E-152-1993-0-CA-04 VECTOR PARTICLES RESISTANT TO INACTIVATION BY HUMAN SERUM CA National Stage 2137361 Abandoned
NCI E-146-1992-0-DK-16 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY DK EP 93911242.1 Expired
NCI E-146-1992-0-LU-19 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY LU EP 93911242.1 Expired
NCI E-146-1992-0-AT-04 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY AT EP 93911242.1 Expired
NCI E-146-1992-0-BE-15 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY BE EP 93911242.1 Expired
NCI E-146-1992-0-IE-18 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY IE EP 93911242.1 Expired
NCI E-146-1992-0-GR-17 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY GR EP 3034641 Expired
NCI E-146-1992-0-IT-13 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY IT EP 93911242.1 Expired
NCI E-146-1992-0-SE-03 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY SE EP 93911242.1 Expired